---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-068591"
form_type: "8-K"
ticker: "OVID"
cik: "0001636651"
company_name: "Ovid Therapeutics Inc."
filed_at: "2023-12-06T23:59:59+00:00"
generated_at: "2026-06-07T17:07:36.996744+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Ovid Therapeutics CEO gifts 1.15M shares to family trusts for estate planning

## Summary
- CEO Jeremy Levin gifted 1,146,500 shares of Ovid common stock to family trusts for his two daughters.
- After gift, Dr. Levin holds 3,598,467 shares of outstanding common stock.
- Transfers made for no consideration as part of year-end estate tax planning.
- Form 4 filed with SEC on December 6, 2023 reporting the gifts.

## SEC filing metadata
- accession: 0000950170-23-068591
- form_type: 8-K
- ticker: OVID
- cik: 0001636651
- company_name: Ovid Therapeutics Inc.
- filed_at: 2023-12-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1636651/000095017023068591/0000950170-23-068591-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1636651/000095017023068591/ovid-20231204.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-068591
- JSON: https://secwatch.observer/filing/0000950170-23-068591.json
- Plain text: https://secwatch.observer/filing/0000950170-23-068591.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.